Dogwood Therapeutics (DWTX) Other Non-Current Assets (2024 - 2026)
Dogwood Therapeutics (DWTX) posted quarterly Other Non-Current Assets of $18719.0 for Q1 2026, up 3.13% year-over-year from $18150.0 in Q1 2025, and down 1.67% quarter-over-quarter from $19037.0 in Q4 2025.
Dogwood Therapeutics (DWTX) Other Non-Current Assets (2024 - 2026) Analysis & Trends
Dogwood Therapeutics (DWTX) has reported Other Non-Current Assets for 3 consecutive years, with $18719.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 3.13% year-over-year to $18719.0; the TTM figure through Mar 2026 stood at $18719.0 (up 3.13% YoY), while the FY2025 annual figure was $19037.0, up 4.99% from the prior year.
- Other Non-Current Assets fell to $18719.0 in Q1 2026 per DWTX's latest filing, from $19037.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $19125.0 in Q2 2025 and bottomed at $18133.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $18651.2 across 3 years, with a median of $18731.0 in 2025.
- Annual changes were most pronounced in 2025 — Other Non-Current Assets climbed 4.99% — and 2026, when it increased 3.13%.
- Dogwood Therapeutics' Other Non-Current Assets stood at $18133.0 in 2024, then rose by 4.99% to $19037.0 in 2025, then declined by 1.67% to $18719.0 in 2026.
- Business Quant data shows DWTX's Other Non-Current Assets at $18719.0 in Q1 2026, $19037.0 in Q4 2025, and $18743.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Dogwood Therapeutics | 84.98 Mn | 84.98 Mn | - | 18,362.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,719.00 |
| Dec 31, 2025 | 19,037.00 |
| Sep 30, 2025 | 18,743.00 |
| Jun 30, 2025 | 19,125.00 |
| Mar 31, 2025 | 18,150.00 |
| Dec 31, 2024 | 18,133.00 |